🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase II, open-label, prospective, single-arm clinical study desi...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2024-09-21
Trial ID
NCT06655259
Treatments Being Tested
The aim of this study is to estimate the PSA response rate with the use of ...
Status
Terminated
Location
Inova Schar Cancer Institute
Start Date
2017-01-06
Trial ID
NCT03261336
Treatments Being Tested
Background: Metastatic castration sensitive and castration resistant prost...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2021-02-23
Trial ID
NCT04633252
Treatments Being Tested
Evaluation of the impact of metastasis-directed therapy in patients with ca...
Status
Recruiting
Location
University Hospitals Leuven
Start Date
2023-12-19
Trial ID
NCT06585007
Treatments Being Tested
The optimal treatment for oligometastatic prostate cancer (OMPC) is still o...
Status
Not Yet Recruiting
Location
the First Affiliated Hospital of Guangzhou Medical University
Start Date
2024-05-01
Trial ID
NCT05707468
Treatments Being Tested
The goal of this clinical trial is to learn if long-term use of memantine h...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-11
Trial ID
NCT07164794
Treatments Being Tested
This study is a single-arm, multicenter, phase II exploratory trial. The pu...
Status
Not Yet Recruiting
Location
Qilu hospital
Start Date
2024-07-31
Trial ID
NCT06500247
Treatments Being Tested
The primary objective of the study is to determine the therapeutic dose of ...
Status
Active Not Recruiting
Location
State Budgetary Healthcare Institution of the Arkhangelsk Region "Arkhangelsk Oncology Dispensary"
Start Date
2024-10-24
Trial ID
NCT07553988
The purpose of the study is to demonstrate superiority of Saruparib (AZD530...
Status
Recruiting
Location
Research Site
Start Date
2025-08-06
Trial ID
NCT06952803
Treatments Being Tested
This study will assess the efficacy and safety of capivasertib plus abirate...
Status
Active Not Recruiting
Location
Research Site
Start Date
2020-07-13
Trial ID
NCT04493853
Treatments Being Tested